Detalhe da pesquisa
1.
Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists.
Bioorg Med Chem Lett
; 22(22): 6876-81, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23046963
2.
Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.
Bioorg Med Chem Lett
; 22(15): 4951-4, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22749826
3.
Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
Bioorg Med Chem
; 17(16): 5989-6002, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620010
4.
Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.
Bioorg Med Chem
; 16(18): 8607-18, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18752960
5.
Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
Bioorg Med Chem
; 16(1): 144-56, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17951061
6.
A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Eur J Pharmacol
; 563(1-3): 224-32, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17336292
7.
In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.
Biochem Biophys Res Commun
; 339(4): 1217-23, 2006 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16343433
8.
A novel, selective, and orally available antagonist for CC chemokine receptor 3.
J Pharmacol Exp Ther
; 317(1): 244-50, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16339911